- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Harris & Harris Group, Inc. (NASDAQ: TINY) today announced the launch of its new website, its blog, its Facebook presence, its YouTube channel and its new logo. The website can be accessed at www.hhvc.com. Harris & Harris Group can be found on Facebook at www.facebook.com//pages/Harris-Harris-Group-Inc/218773771535990?sk=wall&filter=1. The blog is hosted on the website at www.hhvc.com/blog. Videos on YouTube can be accessed at www.youtube.com/user/hhvcportfoliovideos/feed.
"As Harris & Harris Group's nanotechnology investment thesis begins to be realized, we believe this new website provides investors and potential investors with better information regarding Harris & Harris Group, its nanotechnology focus and the progress of our portfolio companies. Nanotechnology is a complex topic for many in the investment community to grasp, but the addition of pictures, videos and portfolio company releases permits the public to see and feel the results of this transformative technology," said Executive Vice President and Managing Director, Misti Ushio.
The blog will be used to provide perspectives in three areas: 1) Harris & Harris Group as a public company; 2) exciting breakthroughs and trends in nanotechnology; and 3) sectors and industries within these sectors impacted by nanotechnology.
Facebook provides Harris & Harris Group with an interactive social forum to better disseminate information, pictures and videos from its portfolio companies. Harris & Harris Group plans to use Facebook to keep shareholders and the public aware of events and advances within the portfolio.
About Harris & Harris Group, Inc.
Harris & Harris Group is an early-stage, active investor in transformative nanotechnology companies. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com.
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2010, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references to the websites www.HHVC.com, www.facebook.com and www.youtube.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.
For more information, please click here
Copyright © Harris & Harris Group, Inc.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Nanoantenna lighting-rod effect produces fast optical switches October 24th, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
New nanomedicine approach aims to improve HIV drug therapies October 24th, 2016